TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea flag South Korea · Delayed Price · Currency is KRW
756.00
+9.00 (1.20%)
At close: Mar 6, 2026
-42.51%
Market Cap 27.25B
Revenue (ttm) 43.68B
Net Income (ttm) -33.51B
Shares Out 36.05M
EPS (ttm) -805.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 299,213
Average Volume 604,243
Open 750.00
Previous Close 747.00
Day's Range 739.00 - 774.00
52-Week Range 689.00 - 4,433.33
Beta 0.91
RSI 34.78
Earnings Date Mar 19, 2026

About TELCON RF PHARMACEUTICAL.

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea. [Read more]

Sector Technology
Founded 1999
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 200230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.